Two Sigma Advisers
CGEM icon

Two Sigma Advisers’s Cullinan Oncology CGEM Stock Holding History

Two Sigma Advisers’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-129,809
Closed -$1.34M – 409
2025
Q4 		$1.34M Buy
129,809
+92,509
+248% +$834K ﹤0.01% 1340
2025
Q3 		$221K Buy
+37,300
New +$273K ﹤0.01% 2096
2025
Q2 		– Sell
-25,100
Closed -$190K – 2340
2025
Q1 		$190K Buy
25,100
+3,200
+15% +$30.7K ﹤0.01% 2152
2024
Q4 		$267K Buy
21,900
+4,000
+22% +$57.5K ﹤0.01% 2027
2024
Q3 		$300K Sell
17,900
-2,900
-14% -$51.4K ﹤0.01% 1908
2024
Q2 		$363K Buy
20,800
+1,200
+6% +$25.6K ﹤0.01% 2001
2024
Q1 		$334K Sell
19,600
-19,000
-49% -$294K ﹤0.01% 2030
2023
Q4 		$393K Buy
+38,600
New +$342K ﹤0.01% 2010
2022
Q4 		– Sell
-15,000
Closed -$192K – 2529
2022
Q3 		$192K Buy
+15,000
New +$202K ﹤0.01% 2214

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return